Welcome : Guest

Alembic Pharmaceuticals Ltd. (India) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Alembic Pharmaceuticals Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 103 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-11941
Price: $3500
Company Type: Public
Pages: 105
Date: March 2016
Market Data Tables: 103

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Alembic Pharmaceuticals Ltd.’s (Operations) Sales by Geographical Region Worldwide (2014-2015) in Percentage for India and International......3
Table 2: Alembic Pharmaceuticals Ltd.’s (Operations) Sales by Product Segment Worldwide (2014-2015) in Percentage for Bulk Drugs, Chemicals and Intermediates, Formulations - Tablets and Capsules, Formulations - Injectables, Formulations - Oral Preparation and Ointments and Others......4
Active Pharmaceutical Ingredients (API)......5
Table 3: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......5
Table 4: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others......6
Table 5: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2014) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......7
Table 6: Pharmaceuticals Services and Active Ingredients (PSAI) Segment Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America and Rest of the World......8
Table 7: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2014) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......9
Analgesic Molecules......10
Table 8: Analgesic Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Aspirin, Ibuprofen, Paracetamol and Others......10
Antibiotics......11
Table 9: Antibiotics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......11
Table 10: Antibiotic Market by Drug Type in the US (2015) - Percentage Share Breakdown by Podiatrists Prescription for Cephalosporins, Macrolides, Penicillins, Quinolones, and Tetracyclines......12
Table 11: Antibiotics Market by Category in China (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......13
Biologics......14
Table 12: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......14
Table 13: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......15
Table 14: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......16
Cough & Cold Drugs......17
Table 15: Cough-Cold Medication Market by Product in the US (2015) - Percentage Share Breakdown by Value for Anticholinergics, Antihistamines, Benzonatate, Expectorants, Triple Combinations and Other......17
Table 16: Cough-Cold Medication (Narcotics & Non-Norcotics) Market by Product in the US (2015) - Percentage Share Breakdown by Value for Benzonatate, Codeine, Dextromethorphan and Hydrocodone......18
Cardiovascular Market......19
Table 17: Cardiovascular Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......19
Table 18: Cardiac & Vascular Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Americas, Asia and Others, Europe, and Japan......20
Cardiology Market......21
Table 19: Cardiology Market by Category in the US (2014) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......21
Table 20: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......22
Diabetes Drugs......23
Table 21: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......23
Table 22: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......24
Table 23: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......25
Table 24: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......26
Table 25: Therapeutics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antidiabetics, Asthma/COPD, Autolmmune, Lipid Regulators, Oncologicsm, and Others......27
Table 26: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......28
Table 27: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......29
Table 28: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......30
Table 29: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......31
Table 30: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......32
Table 31: Therapeutic Classes Market by Segment in the US (2014) - Percentage Market Share Breakdown by Value Sales for Antidiabetics, Antihypertensives, Autoimmune Diseases, HIV Antivirals, Lipid Regulators, Mental Health, Oncologics, Pain, Respiratory Agents, and Others......33
Diabetic Macular Edema (DME)......34
Table 32: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......34
Table 33: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2014) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......35
Diabetes Market......36
Table 34: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......36
Table 35: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......37
Table 36: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......38
Table 37: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......39
Table 38: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......40
Table 39: Type 1 Diabetes Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Continuous Glucose Monitoring Users, and Non-Continuous Glucose Monitoring Users......41
No. of Diabetes Patients......42
Table 40: Diagnosed Narcolepsy Patients Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Current Xyrem Patient, Untreated Diagnosed Patients and WF Peak Additional Xyrem Patients......42
Table 41: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......43
Gastrointestinal Drugs......44
Table 42: Gastrointestinal Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......44
Table 43: Therapy Market by Type in Russia (2015) - Percentage Share Breakdown by Value for Gastrointestinal, Pain, Respiratory, Vitamins, and Others......45
Gastroparesis......46
Table 44: Gastroparesis Market by Cause Worldwide (2015) - Percentage Share Breakdown by Volume for Diabetic, Idiopathic, Surgery and Other......46
Table 45: Gastroparesis Market by Cause in the US (2015) - Percentage Share Breakdown by Value for Diabetic, Idiopathic, Surgery and Other......47
Ophthalmic Drugs......48
Table 46: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......48
Table 47: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......49
Glaucoma Drugs......50
Table 48: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......50
Table 49: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......51
Table 50: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......52
Table 51: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......53
Ophthalmology Market......54
Table 52: Ophthalmology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Ophthalmic pharmaceuticals, Surgical, and Vision Care......54
Table 53: Ophthalmology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cataract & Vitreoretinal Surgery, Ophthalmic Lasers, and Vision Care......55
Urology Market......56
Table 54: Urology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Basic Drainage, Catheter Stabilization, Continence, Temperature Management, and Urological Specialties......56
Table 55: Urology Care Market by Region Worldwide (2014) - Percentage Share Breakdown for Europe, North America, and Rest of World (RoW)......57
Table 56: Urology Market by Category in North America and Europe (2014) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis / Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......58
Urology and Gynaecology Market......59
Table 57: Urology and Gynaecology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Dialysis Equipment, Gynaecology Devices, Urinary Catheters, and Urology Devices......59
Pharmaceuticals......60
Table 58: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......60
Table 59: Specialty Inflammatory Conditions Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......61
Table 60: OTC Drug Sales by Category in China (2014) - Percentage Market Share Breakdown by Value for Anti-Inflammatory, Cold, Gastrointestinal, Gynecological, Minerals, Tonics, Vitamins, Supplements, and Others......62
Analgesics Drugs......63
Table 61: Market Shares of Leading Analgesics Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......63
Table 62: Market Shares of Leading Anaesthetics & Analgesics Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......64
Table 63: Market Shares of Leading Analgesics Manufacturers in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......65
Table 64: Market Shares of Leading Analgesics Manufacturers in Asia-Pacific (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......66
Table 65: Market Shares of Leading Drug (Analgesics Capsule) Companies in China (2015) - Percentage Breakdown by Value for Beijing Novartis Pharma Ltd., GlaxoSmithKline (Tianjin) Co., Ltd., Tibet Cheezheng Tibetan Medicine Company Ltd., Yunnan Baiyao Group, and Others......67
Table 66: Market Shares of Leading Analgesics Manufacturers in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......68
Table 67: Market Shares of Leading Analgesic Product Manufacturers in India (2015) - Percentage Share Breakdown by Value for Emami Ltd., Glaxo SmithKline Consumer Healthcare Ltd., Reckitt Benckiser Group Plc, and Others......69
Table 68: Market Shares of Leading Analgesic Products Brands in India (2015) - Percentage Share Breakdown by Value for Zandu Balm & Mentha Balm, and Others......70
Table 69: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Volume for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......71
Table 70: Market Shares of Leading Analgesics Manufacturers in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......72
Table 71: Market Shares of Leading Analgesic Brands in Nigeria (2015) - Percentage Breakdown by Value for Alabukun, Emzor, Pandol, and Others......73
Table 72: Market Shares of Leading Analgesics Manufacturers in North America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......74
Table 73: Market Shares of Leading Analgesic (Internal Tablet) Manufacturers by Value Sales at Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Bayer Consumer Health Division, McNeil Consumer Products, Pfizer, Inc., Private Label, and Others......75
Anti-Infectives......76
Table 74: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Other......76
Cough & Cold Drugs......77
Table 75: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC Worldwide (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others......77
Table 76: Market Shares of Leading Cough, Cold Allergy Medicine Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, and Others......78
Table 77: Market Shares of Leading Manufacturers for Cough and Cold Remedies Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., Reckitt Benckiser Group Plc, Sanofi S.A., Private Label and Others......79
Table 78: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......80
Table 79: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Asia-Pacific (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others......81
Table 80: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Procter & Gamble Co., and Others......82
Table 81: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Procter & Gamble Co., and Others......83
Table 82: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in North America (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others......84
Table 83: Market Shares of Leading Cough & Cold Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......85
Table 84: Market Shares of Leading Cough & Cold Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......86
Table 85: Market Shares of Leading Cough and Cold Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Johnson & Johnson Private Limited, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Private-Label and Others......87
Table 86: Market Shares of Leading Cough/Cold Remedy Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Johnson & Johnson, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser plc., Sanofi S.A. Private Label, and Others......88
Cardio Cerebral Vascular (CCV) Drugs......89
Table 87: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015) - Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd., Sanofi S.A., Qilu pharmaceutical Co., Ltd. and Others......89
Cardiology Therapeutics......90
Table 88: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......90
Diabetes Drugs......91
Table 89: Market Shares of Leading Drug Sales for GLP-1 based Diabetes Worldwide (2014) - Percentage Breakdown by Value for Albilgutide, Bydureon, Byetta, Dulaglutide, Lixumia and Victoza......91
Table 90: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......92
Table 91: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......93
Table 92: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......94
Gastrointestinal Drugs......95
Table 93: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & JohnsonPfizer, Inc., and Others......95
Table 94: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private-Label and Others......96
Table 95: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......97
Table 96: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......98
Ophthalmology Therapeutics......99
Table 97: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......99
Ophthalmic Steroids......100
Table 98: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......100
Retinal Drugs......101
Table 99: Market Shares of Leading Retinal Companies Worldwide (2014) - Percentage Share Breakdown by Value for Alcon Incorporated, Bausch & Lomb, Dutch Ophthalmic Research Center International BV, Iridex Corporation, Synergetics, Inc., and Others......101
Pharmaceuticals......102
Table 100: Market Shares of Leading Anti-Inflammatory Biologic Brands Worldwide (2015) - Percentage Share Breakdown by Value for Actemra, Enbrel, Humira, Remicade and Others......102
Table 101: Market Shares of Leading Pharmaceutical Companies in India (2014) - Percentage Breakdown by Value for Abbott India Limited, Alembic Pharmaceuticals Limited, Alkem Laboratories, Aristo Pharmaceuticals Pvt Ltd., Cadila Pharmaceuticals Limited., Cipla Global Limited, Dr. Reddy's Laboratories., Emcure Pharmaceuticals Ltd., FDC Limited., GlaxoSmithKline Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Intas Pharmaceuticals limited, Lupin Limited, Macleods Pharmaceuticals Ltd., Mankind Pharma, Micro Labs Ltd., Novartis AG, Pfizer Limited, India., Ranbaxy Laboratories Limited, Sanofi India Limited, Sun India Pharmacy (P) Ltd., Torrent Pharmaceuticals Limited., Unichem Laboratories, USV Limited., Wockhardt Ltd., and Others......103
Table 102: Alembic Pharmaceuticals Ltd.’s (Operations) Sales by Geographical Region Worldwide (2013-2014) in Percentage for India and International......104
Table 103: Alembic Pharmaceuticals Ltd.’s (Operations) Sales by Product Segment Worldwide (2013-2014) in Percentage for Bulk Drugs, Chemicals and Intermediates, Formulations - Tablets and Capsules, Formulations - Injectables, Formulations - Oral Preparation and Ointments and Others......105